Sherlock Biosciences

About

Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.

Cambridge,Massachusetts,United States
51 - 100
https://sherlock.bio/

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $1.98M
Industries: Biotechnology,Health Care,Health Diagnostics,Life Science
Founded date: Jan 1, 2019
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Sherlock Biosciences, Inc.

Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions. It leverages engineering biology tools, including CRISPR and Synthetic Biology, to create molecular diagnostics that can rapidly deliver accurate results for a vast range of needs in virtually any setting. They combine the diagnostic power of SHERLOCK with that of a second core platform technology, Internal Splint-Pairing Expression Cassette Translation Reaction, or INSPECTRTM, to create diagnostic tools that are simple and easy to use in virtually any setting, and at the same time provide accurate, rapid and affordable results.

SheSherlock Biosciences was founded in 2019 and is headquartered in Cambridge, Massachusetts, United States.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$137.98M

Sherlock Biosciences has raised a total of $137.98M in funding over 2 rounds. Their latest funding was raised on Nov 29, 2022 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 29, 2022	Grant	—	1	—	—	Detail
Mar 8, 2022	Series B	$80M	6	Novalis LifeSciences	—	Detail
Jan 1, 2022	Series Unknown	$1.98M	1	Alameda Research	—	Detail
May 21, 2020	Grant	$7.50M	1	Open Philanthropy Project	—	Detail
Apr 23, 2019	Series A	$31M	3	Northpond Ventures	—	Detail

Investors

Number of Lead Investors

Number of Investors

5

10

Sherlock Biosciences is funded by 10 investors. Novalis LifeSciences and Alameda Research are the most recent investors.

Investor Name	Lead Investor	Funding Round
Novalis LifeSciences	Yes	Series B
Alameda Research	Yes	Series Unknown
Open Philanthropy Project	Yes	Grant
Bill & Melinda Gates Foundation	—	Grant
Albany Capital	—	Series B
Catalio Capital Management	—	Series B
Good Ventures	—	Series B
Illumina Ventures	—	Series B
Northpond Ventures	—	Series B
Baidu Ventures	—	Series A